3-Year Manhunt Ends as Key Figure in ₹25 Crore Fake Cancer Drug Syndicate Captured
In a significant breakthrough, Delhi Police have apprehended Sabir Alam, a central figure in a ₹25 crore counterfeit cancer drug operation, after a relentless three-year pursuit. Alam was arrested on May 20 in Bardhaman, West Bengal, while on his honeymoon, following a critical tip-off and extensive surveillance.
The investigation into this illicit network began in November 2022, leading to the arrest of 14 individuals, including two doctors. Authorities uncovered a clandestine manufacturing unit in Sonipat, Haryana, and a warehouse in Tronica City, Uttar Pradesh, where counterfeit medications were produced and stored. The syndicate’s modus operandi involved refilling empty vials of expensive cancer drugs with inexpensive substances like antifungal agents and selling them at exorbitant prices ranging from ₹1 lakh to ₹3 lakh per vial.
Alam played a pivotal role in distributing these fake medications in Kolkata and coordinating shipments to Bangladesh, where they were supplied to an associate identified as Dr. Rasel. He also managed financial transactions, collecting payments from unsuspecting patients and transferring proceeds to co-conspirators after retaining his share.
Following the arrest of his associates, Alam went into hiding, maintaining a low profile. His capture marks a significant milestone in dismantling the counterfeit drug network that jeopardized the lives of countless cancer patients.
2026-10-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
“Soaring Sulfuric Acid, Tightening Ore Supplies”: The High-Stakes Battle Behind the Titanium Dioxide Price Surge
-
Egypt’s Chemical Surge: $9.4 Billion Export Boom Signals Industrial Powerhouse Rise
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Aekyung Chemical Plans to Sell Its Ningbo Subsidiary
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
-
Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6
-
Behind Japan's Tungsten Hexafluoride Crisis: Can China's Electronic Specialty Gases Seize a New Opportunity?
-
BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion
Recommend Reading
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
South Korea Tests Arctic Commercial Route as Asian Exporters Seek New Logistics Alternatives
-
New Titanium Dioxide Alternative Moves Closer to Market
-
Rising API Costs Threaten Drug Prices
-
Korea’s First Petrochemical Restructuring Approved, LDPE Market Concentration Surges to 82%
-
Business Society’s Market Outlook for Dichloromethane on August 25, 2026: Clearly Upward Trend
-
Supply-Demand Gap Widens, Lithium Carbonate Prices Approach Year-to-Date High
-
Business Society’s DOP Market Outlook on August 25, 2026: Strong Volatility
-
Business Society’s Market Outlook for Hydrofluoric Acid on August 25, 2026: A Volatile Pattern
-
Premium Global Chemical Sourcing Requests (12 - 16 Jan, 2026)